Butler Richard J, Robinson Joanne C, Holland Philip, Doherty-Williams Diane
Child & Adolescent Mental Health Service, East Leeds Primary Care Trust, UK.
Scand J Urol Nephrol. 2004;38(2):117-21. doi: 10.1080/00365590410025371.
Nocturnal enuresis is a heterogeneous condition with various treatment options of both pharmacological and psychological origin. The three systems model previously proposed by us suggests a framework to facilitate understanding, identify a child's needs and specify the appropriate treatment option. In this study we sought to investigate the model in clinical practice in a group of children with severe nocturnal enuresis, with particular reference to pharmacological treatment.
A total of 66 children were assessed using a schedule for identifying mono- and non-monosymptomatic nocturnal enuresis, and were administered either desmopressin (0.4 mg) or anticholinergic medication (5-10 mg), respectively. Children were assessed at 4 weeks, with those failing to meet the success criterion being offered combination treatment for a further 4 weeks.
Success rates for monotherapy were 49% and 33% for desmopressin and anticholinergic medication, respectively, with an overall success rate of 74.5%, including those who went on to combination treatment. Good clinical signs were identified for those successfully treated with anticholinergic medication.
This study endorses the three systems approach in clinical practice.
夜间遗尿是一种异质性病症,有多种源于药理学和心理学的治疗选择。我们之前提出的三系统模型提供了一个框架,有助于理解病情、确定儿童的需求并明确合适的治疗方案。在本研究中,我们试图在一组重度夜间遗尿儿童的临床实践中研究该模型,尤其涉及药物治疗。
总共66名儿童接受了用于识别单症状和非单症状夜间遗尿的评估表评估,并分别给予去氨加压素(0.4毫克)或抗胆碱能药物(5 - 10毫克)。在4周时对儿童进行评估,未达到成功标准的儿童再接受4周的联合治疗。
去氨加压素和抗胆碱能药物单药治疗的成功率分别为49%和33%,包括接受联合治疗的儿童在内,总体成功率为74.5%。确定了抗胆碱能药物治疗成功的儿童的良好临床体征。
本研究支持在临床实践中采用三系统方法。